Search results for: France
Filter search results
Comparing Prescription Medicines Prices in the UK to Prices in Other Countries
23 October 2012
…Finland, France, Germany, Ireland, Italy, The Netherlands, Spain, Sweden and the US. To ensure the medicines included do match, various databases were used. The total sample of preparations included in…
Is It Time to Reconsider the Role of Co-Payments in Europe?
11 January 2012
…co-pays The Netherlands and Malta 2. Flat-rate Austria, Italy, UK (with implicit ceiling prescription pre-payment certificate) 3. Percentage rates Belgium, France, Greece, Estonia, Finland (with annual ceiling), Latvia, Lithuania, Poland,…
OHE in the Spotlight: Summer 2011
22 September 2011
…Towse chaired a session of experts from the UK, the US and France that focused primarily on the role VBP would have in aligning the incentives for investment in pharmaceutical…
The Spanish Medicines Market Today
9 February 2011
…half of the average of 2% for the five largest European markets. Reimbursement over the same period grew 2.3%, above Italy’s -1.2%, but well below France at 3.3%, the UK…
Access to Orphan Drugs in the EU
21 October 2010
…late September. The OHE study compares P&R policy for 43 OMPs across seven EU Member States: France, Germany, Italy, The Netherlands, Spain, Sweden and the UK. In particular, the study…
HTA and Payment Mechanisms for New Drugs to Tackle AMR
23 September 2019
…of the current state of HTA and contracting for antibiotics in France, Germany, Italy, Sweden, and the UK (England and Scotland), and of the recent proposals in the literature for…
Measuring the Benefits of Medicines: The Future Agenda
1 March 1990
…Europe. In his keynote speech. Sir Christopher France referred to health economics as having ‘come of age’ because the first health economist in the then Ministry of Health in London…
Biosimilars’ Price Dynamic in Europe
30 June 2010
…seminar and summarises the remarks of Dr Matthias Liefner of Simon Kucher and Partners. In Europe, pricing of biosimilars already has begun to affect the market for biologics. For example, France’s compulsory…
Childhood Vaccination: Current Controversies
1 July 1984
…at the end of the eighteenth century with Jenner’s demonstration that smallpox could be prevented by first ‘vaccinating’ individuals with cowpox. Eighty years later, the work of Pasteur in France…